L. Ford

发表

Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma With Self-reported Chronic Rhinosinusitis.

I. Pavord, W. Busse, K. Rabe, 2020, The journal of allergy and clinical immunology. In practice.

Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma.

D. Kellerman, K. Faulkner, L. Ford, 1999, The Journal of allergy and clinical immunology.

A. Crimmins, L. Ziska, K. Knowlton, 2019, The Lancet. Planetary health.

A comparison of fluticasone propionate nasal spray and cetirizine in ragweed fall seasonal allergic rhinitis.

L. Ford, J. Matz, B. Prillaman, 2015, Allergy and asthma proceedings.

Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthma

D. Halpin, M. Castro, C. Katelaris, 2021, European Respiratory Journal.

Dupilumab Efficacy and Safety in Moderate‐to‐Severe Uncontrolled Asthma

I. Pavord, W. Busse, K. Rabe, 2018, The New England journal of medicine.

Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma.

M. K. Ruddy, I. Pavord, E. Israel, 2021, The New England journal of medicine.

Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study.

I. Pavord, H. Watz, M. Wechsler, 2021, The Lancet. Respiratory medicine.

Dupilumab improves clinical outcomes in patients with asthma and perennial allergic rhinitis.

W. Busse, N. Hanania, N. Graham, 2020, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Dupilumab improves asthma outcomes irrespective of frequency of previous asthma exacerbation history.

M. Castro, J. Bernstein, S. Jayawardena, 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

P219 DUPILUMAB IS WELL TOLERATED AND SHOWS SUSTAINED EFFICACY IN PATIENTS WITH ASTHMA: LIBERTY ASTHMA TRAVERSE

I. Pavord, H. Watz, M. Wechsler, 2020 .

Dupilumab Suppresses Inflammatory Biomarkers in Asthma Patients With or Without Allergic Rhinitis: Post Hoc Analysis of the LIBERTY ASTHMA QUEST Study: 294

W. Busse, J. Bousquet, N. Hanania, 2019, Journal of Allergy and Clinical Immunology.

Dupilumab efficacy in asthma patients with comorbid chronic rhinosinusitis or nasal polyposis (CRS/NP) in LIBERTY ASTHMA QUEST

I. Pavord, K. Rabe, B. Cosío, 2018, Allergy and immunology.

A Randomized, Controlled Phase 3 Study, LIBERTY ASTHMA QUEST, Evaluating the Efficacy and Safety of Dupilumab in Uncontrolled Moderate-to-Severe Asthma

I. Pavord, W. Busse, K. Rabe, 2018 .

Joint association between ambient air pollutant mixture and pediatric asthma exacerbations

J. Poole, L. Ford, Yeongjin Gwon, 2022, Environmental epidemiology.

Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma

I. Pavord, W. Busse, K. Rabe, 2018, Advances in Therapy.

Late Breaking Abstract - Dupilumab long-term safety and efficacy in patients with asthma: LIBERTY ASTHMA TRAVERSE

I. Pavord, H. Watz, M. Wechsler, 2020 .

Dupilumab in persistent asthma with elevated eosinophil levels.

S. Wenzel, G. Yancopoulos, N. Stahl, 2013, The New England journal of medicine.

Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma.

L. Edwards, J. Condemi, L. Ford, 1997, The Journal of allergy and clinical immunology.

Efficacy and safety of fluticasone propionate 250 microg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids.

L. Edwards, W. Lincourt, R. Nathan, 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Recent warming by latitude associated with increased length of ragweed pollen season in central North America

Jonathan A. Patz, J. Patz, L. Ziska, 2011, Proceedings of the National Academy of Sciences.

Cannabis (hemp) positive skin tests and respiratory symptoms.

T. Casale, R. Hartel, L. Ford, 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Dupilumab Suppresses Type 2 Biomarkers in Asthma Patients With and Without Comorbid Chronic Rhinosinusitis With or Without Nasal Polyposis (CRS/NP): Post Hoc Analysis of LIBERTY ASTHMA QUEST: 296

A. Peters, J. Corren, B. Chipps, 2019, Journal of Allergy and Clinical Immunology.

Dupilumab Improves Lung Function and Reduces Severe Exacerbation Rate in Patients With Uncontrolled, Moderate‐to‐Severe Asthma With or Without Comorbid Allergic Rhinitis: Results From the Phase 3 LIBERTY ASTHMA QUEST Study: 293

W. Busse, N. Hanania, M. Fitzgerald, 2019, Journal of Allergy and Clinical Immunology.

Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid Dose.

D. Halpin, N. Hanania, B. Ortiz, 2022, The journal of allergy and clinical immunology. In practice.